Efficacy and tolerability of acemetacin, a non-steroidal anti-inflammatory drug, in Mexican patients: result of the ETAPAM Study.
Bori Segura
Gerardo
G
Rheumatology Department, Hosp. Gral. de Zona Villa Coapa D.F.
Torres y Gutierrez Rubio
Arturo
A
Herrera Gómez
Luis Eduardo
LE
Olguín Uribe
Jorge
J
D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use*; D001265:Athletic Injuries / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D008297:Male; D008800:Mexico; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D010147:Pain Measurement; D011446:Prospective Studies; D012216:Rheumatic Diseases / Q000150:complications / Q000188:drug therapy*
D000894:Anti-Inflammatory Agents, Non-Steroidal; C026784:acemetacin; D007213:Indomethacin